Tissue Regenix Group

Tissue Regenix was established in May 2006 and is dedicated to the development of clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as Vascular and Orthopaedic medicine. There is a well established clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialise acellular tissue repair products to meet this need, to ultimately benefit patients.
Swillington, GB
60 (est)

Tissue Regenix Group Locations

Swillington, GB
San Antonio, US

Tissue Regenix Group Metrics

Tissue Regenix Group Summary

Founding Date


Market capitalization

£133 M

Closing share price


Tissue Regenix Group Market Value History

Tissue Regenix Group Company Life